logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
T

Therapeutic Advances in Medical Oncology

IF4.2
Papers1882
Citations5013
Journal Papers 1866
Publication Date
delete
Longitudinal dynamics and recovery of lymphocytes in patients with breast cancer receiving radiotherapy without chemotherapy after breast-conserving surgery: A second analysis of a phase III randomized trial of HYPOfractionation in BREAST radiotherapy for Chinese women (CHN HYPOBREAST)
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-09-29
delete0
PREAI
deleteYu-Chun Song; Chao-Nan Zhang; Guang-Yi Sun; Xu-Ran Zhao; Si-Ye Chen; Zi-Han Qiu; Hao Jing; Hui Fang; Yu Tang; Yong-Wen Song; Jing Jin; Yue-Ping Liu; Bo Chen; Yuan Tang; Shu-Nan Qi; Ning-Ning Lu; Ning Li; Yi-Rui Zhai; Wen-Wen Zhang; Xin Liu; Zhuan-Bo Yang; Ye-Xiong Li; Shu-Lian Wang
deleteShare
deleteSave
Clinicopathologic and molecular features of head and neck NUT carcinoma: Analysis of 25 cases, including 5 with adenoid differentiation
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-09-21
delete0
PREAI
deleteYunyun Yang; Yue Hao; Chunwei Xu; Yahui Li; Xiaochen Li; Honggang Liu; Yingshi Piao
deleteShare
deleteSave
Adjuvant FOLFIRINOX versus S-1 monotherapy for resected PDAC: retrospective real-world data
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-09-04
delete0
PREAI
deleteHui Tang; Zhengxia Li; Tingting You; Jinrong Ying; Yuejuan Cheng; Chunmei Bai; Yingyi Wang
deleteShare
deleteSave
A phase II study of DFP-14323, a non-specific immunomodulator, in combination with low-dose afatinib as first-line therapy for common EGFR mutation-positive NSCLC
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-09-01
delete0
PREAI
deleteHiroshige Yoshioka; Masahide Mori; Nobuyuki Katakami; Toshihide Yokoyama; Hiroyasu Kaneda; Hirotaka Matsumoto; Motohiro Tamiya; Kouji Yamamoto; Cheng-long Huang
deleteShare
deleteSave
Integrating clinical and genomic features to predict response to neoadjuvant therapy in microsatellite-stable rectal cancer
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-31
delete0
PREAI
deleteLijie Zhang; Jingwen Wang; Juefeng Wan; Yan Wang; Hui Zhang; Yaqi Wang; Fan Xia; Lijun Shen; Zhen Zhang
deleteShare
deleteSave
A clinically derived lipid-endothelial signature links serum multi-omics to immune exclusion and clinical stratification in hepatocellular carcinoma
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-31
delete0
PREAI
deleteLuxi Yang; Qiaoying Jin; Lu Chen; Yating Liu; Yumin Li
deleteShare
deleteSave
A review on toxicities of T-cell engager-based therapies in solid tumors
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-30
delete0
PREAI
deleteEtienne Bastien; Clara Vacheret; Raphael Sanchez; Francesca Lucibello; Nicolas Girard; Emanuela Romano
deleteShare
deleteSave
Chemotherapy relative dose intensity and survival outcomes in pediatric and adolescent locoregionally advanced nasopharyngeal carcinoma: A retrospective cohort study
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-29
delete0
PREAI
deleteZi-Xuan Chen; Ye-Hao Zou; Rui-Ling Xie; Ling-Ling Zhang; Chao Lin; Rui Sun
deleteShare
deleteSave
Efficacy comparison of first-line treatment regimens for stage IV esophageal squamous cell carcinoma with supraclavicular lymph node metastasis: A study of the oligometastatic subtype
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-28
delete0
PREAI
deleteFengyi Wang; Rong Yu; Wei Zhang; Dan Han; Wei Deng; Chengxin Liu; Shixuan Zhou; Yifei Wang; Chao Bai; Mingxia Shao; Chen Wang; Yifei Wang; Wei Huang
deleteShare
deleteSave
Antibody-drug conjugates and beyond in platinum-resistant ovarian cancer: A comprehensive review of emergent strategies
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-26
delete0
PREAI
deleteMariana Macambira Noronha; Luiz Felipe Costa de Almeida; Valbert Oliveira Costa Filho; Laura Venegas; Mariana Carvalho Gouveia; Ana C Veneziani
deleteShare
deleteSave
NanoString profiling of DNA repair and apoptosis genes in testicular germ cell tumours with divergent chemotherapy outcomes
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-26
delete0
PREAI
deleteNadia Hitchen; Philippe L. Bedard; Neil Winegarden; Joan Sweet; Amanda Grubb; Lynn Anson-Cartwright; Peter Chung; Padraig Warde; Malcolm Moore; Edmond M. Kwan; Ben Tran
deleteShare
deleteSave
DNA methylation features and diagnostic model establishment of MET amplification in lung adenocarcinoma
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-26
delete0
PREAI
deleteShuting Zhan; Jianfu Li; Jinsheng Tao; Hao Yang; Bo Cheng; Caichen Li; Qi Cai; Jian-Bing Fan; Jianxing He; Wenhua Liang
deleteShare
deleteSave
Risk stratification and boost dose optimization for locoregionally advanced nasopharyngeal carcinoma with residual lesions based on clinical stage and post-radiotherapy EBV DNA
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-24
delete0
PREAI
deleteXinyi Hong; Yi Li; Chaoying Lin; Jianxian Chen; Haosheng Zhang; Weijian Liu; Lanxin Lin; Zongying Qian; Sihan Lin; Yuhui Pan; Sufang Qiu
deleteShare
deleteSave
Lorlatinib-specific outcomes by timing of lorlatinib initiation in advanced ALK-positive non-small cell lung cancer: A retrospective cohort study
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-20
delete0
PREAI
deleteRuiqi Song; Xinyue Li; Na Han; Dujiang Liu; Yanjun Xu
deleteShare
deleteSave
Historical evaluation of clinical outcomes and safety following isolated limb perfusion for unresectable melanoma: Real-world data from the Mannheim Cancer Center
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-20
delete0
PREAI
deleteDanai-Dionysia Kanatoula; Sebastian A. Wohlfeil; Corinne Hübers; Janna Eith; Jens Jakob; Peter Hohenberger; Jochen Utikal
deleteShare
deleteSave
Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33—REGAL study
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-20
delete0
PREAI
deleteDavide Bimbatti; Cecilia Nasso; Domiziana Aspden; Sebastiano Buti; Ludovica Antonj; Alessio Signori; Elena Verzoni; Cristian Lolli; Marilena Di Napoli; Martina Fanelli; Miriam De Lucia; Cristina Masini; Giandomenico Roviello; Daniela Arduini; Roberto Filippi; Alessia Mennitto; Mariella Sorarù; Giovanni Bozza; Luigi Formisano; Carlo Messina; Lucia Bonomi; Annalisa Guida; Emanuela Fantinel; Sarah Scagliarini; Maria Giuseppa Vitale; Silvia Chiellino; Brigida Anna Maiorano; Filippo Maria Deppieri; Paolo Andrea Zucali; Alessia Cavo; Claudia Caserta; Francesca La Russa; Vincenza Conteduca; Francesca Maines; Silvia Zai; Francesco Pierantoni; Massimiliano Icardi; Pasquale Rescigno; Fabrizio Di Costanzo; Giuseppe Luigi Banna; Sara Elena Rebuzzi
deleteShare
deleteSave
Clinical outcomes and genomic landscape of anti-HER2 antibody-drug conjugates in HER2-positive and HER2-low metastatic breast cancer
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-20
delete0
PREAI
deleteXiujuan Gui; Haizhu Chen; Jianli Zhao; Hongna Lai; Simin Luo; Jie Chai; Yangyang Cai; Wenjing Wu; Yinduo Zeng; Maojian Chen; Ying Wang; Herui Yao; Linxiaoxiao Ding
deleteShare
deleteSave
Clinical and hematological indices as prognosticators in localized solitary fibrous tumors: A retrospective study
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-18
delete0
PREAI
deleteAriel Yoong Yi KOH; Ryan Mao Heng LIM; Jason Yongsheng CHAN
deleteShare
deleteSave
Comparison of the efficacy and safety of HLX-02 plus pertuzumab versus HLX-02 plus pyrotinib in neoadjuvant therapy for HER2-positive breast cancer
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-18
delete0
PREAI
deleteWeifang Tang; Qilin Zhou; Jianjun Liu; Shikai Hong
deleteShare
deleteSave
Stereotactic radiotherapy for rib metastases from prostate cancer: A multicenter real-world analysis of local control, pain response, and treatment tolerance (RIBRISK)
deleteTherapeutic Advances in Medical Oncology
IF4.2
delete2026-08-18
delete0
PREAI
deleteMateusz Bilski; Federico Mastroleo; Igor Banaszek; Katarzyna Korab; Wojciech Kuźnicki; Nina Jędrzejczak; Magdalena Peszyńska-Piorun; Julia Ponikowska; Jacek Fijuth; Barbara Alicja Jereczek Fossa; Thomas Zilli; Rupesh Kotecha; Shankar Siva; Matthias Guckenberger; Amar Kishan; Łukasz Kuncman
deleteShare
deleteSave